A promising molecule, called BT13, has offered hope for a new treatment that could stop or slow Parkinson’s, something no treatment can currently do.
Researchers from the University of Helsinki have found that molecule BT13 has the potential to both boost levels of dopamine, the chemical that is lost in Parkinson’s, as well as protecting the dopamine-producing brain cells from dying.
The results from the study, co-funded by Parkinson’s UK, showed an increase in dopamine levels in the brains of mice following treatment with the molecule. BT13 also activated a specific receptor in the mouse brains to protect the cells.
These findings suggest that BT13 could have the potential to lead to a new drug treatment that can slow, stop or even reverse the loss of brain cells in Parkinson’s.
Why is dopamine important?
Typically, by the time people are diagnosed with Parkinson’s, they have already lost 70-80 per cent of their dopamine-producing cells. These are involved in coordinating movement.
Current treatments mask the symptoms, but there is nothing that can slow down its progression or prevent more brain cells from being lost. As dopamine levels continue to fall, symptoms get worse and new symptoms can appear.
The role of BT13
Researchers are now working on improving the properties of BT13 to make it more effective as a potential treatment. If successful, this could benefit the 145,000 people living with Parkinson’s in the UK.
The study builds on previous research on another molecule that targets the same receptors in the brain, glial cell line-derived neurotrophic factor (GDNF), an experimental treatment for Parkinson’s which was the subject of a major clinical trial funded by Parkinson’s UK. While the results were not clear cut, GDNF has shown promise to restore damaged cells in Parkinson’s.
The GDNF protein requires complex surgery to deliver the treatment to the brain because it’s a large molecule. However BT13, a smaller molecule, could be more easily administered as a treatment if shown to be beneficial in further clinical trials.
“The molecule holds great promise”
Professor David Dexter, Deputy Director of Research at Parkinson’s UK, said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms.
“One of the biggest challenges for Parkinson’s research is how to get drugs past the blood-brain barrier, so the exciting discovery of BT13 has opened up a new avenue for research to explore.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Mix Talent Sponsors Inaugural 5KforJK Event Which Raises More than $93,000 for Parkinson's Research
The 5KforJK was the first of an annual 5K walk in Powell Ohio on Sunday, October 3rd. More than 500 people attended and raised over $93,000 for The Michael J. Fox Foundation for Parkinson's Research ...
- Mizuho's Parkinson with opportunities in chemicals and packaging
Christopher Parkinson, Mizuho America managing director and senior industrials analyst, takes a look at which stocks can be profitable despite inflation concerns on 'Power Lunch.' ...
- Billy Connolly reveals he has been left heartbroken not being able to write letters due to Parkinson’s disease
SIR Billy Connolly has revealed he’s heartbroken at not being able to write letters anymore. The comedy legend, 78, – who has Parkinson’s disease – says his shakes mean his personal ...
- Manufacturing Commences on Adhera’s MLR-1019 for Phase 2a Clinical Trial Treating Parkinson’s Disease
IP Estate Grows with New Korean Patent Issued Baton Rouge, LA, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCPK: ATRX) ("Adhera" or the "Company"), a clinical stage biopharmaceutical ...
- Billy Connolly says Parkinson’s disease has left him no longer able to write
Comedian Billy Connolly has revealed that he is no longer able to write due to Parkinson’s disease. The revered Scottish entertainer recorded an appearance on the latest episode of The Graham Norton ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
14 hours agoLast updated 14 hours ago Updated Monday to Friday only Today will have a dry and bright start with sunny spells. It will turn cloudier in the afternoon, but it will stay mainly dry ...